Institutional Only|Drovix does not deal with individual investors and does not accept deposits or provide retail trading services.

Drovix.
Order Execution

Order Execution Policy

Drovix (MU) Ltd

Authorized and regulated by the Financial Services Commission (FSC) of Mauritius

Investment Dealer (Full Service Dealer) excluding Underwriting, License No. GB21026813

Registered Address: C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201, Mauritius

Website: www.drovix.com

Effective Date: March 2026

View PDFDownload PDF

1. Introduction

IMPORTANT NOTICE: This document is intended exclusively for institutional investors, professional investors, and qualified counterparties. The Company does not accept retail investors.

Drovix is an alternative asset manager specialising in systematic investing. This Policy sets out arrangements for best possible execution when executing orders and managing portfolios for institutional and professional investors. Order execution is driven by quantitative models and systematic processes.

2. Scope

This Policy applies to all Financial Instruments traded within the Company's authorized scope under its FSC license, primarily FX, indices, commodities, and CFD instruments.

3. Best Execution

When executing orders, the Company takes into account the following factors:

  • Price;
  • Costs;
  • Speed;
  • Likelihood of execution and settlement;
  • Size;
  • Nature of order;
  • Market impact.

Primary consideration: price and total cost.

4. Execution Approach

The Company employs the following in pursuit of best execution:

  • Algorithmic Execution;
  • Smart Order Routing;
  • Transaction Cost Analysis (TCA);
  • Pre-Trade and Post-Trade Controls.

These capabilities support systematic, model-driven portfolio management and execution.

5. Execution Venues

The Company may access execution through:

  • Regulated exchanges;
  • Prime brokers;
  • Institutional liquidity providers;
  • OTC counterparties.

Venue and counterparty selection is based on regulatory standing, pricing quality, liquidity, speed, instrument coverage, settlement reliability, and technology.

6. Instrument-Specific Execution

Execution routes may vary by instrument type as follows:

6.1 Foreign Exchange

Prime brokerage, institutional FX platforms, and aggregated liquidity.

6.2 CFDs on Indices & Commodities

Regulated exchanges, direct liquidity access, and aggregated institutional liquidity providers.

6.3 Exchange-Traded Derivatives

Regulated exchanges, direct liquidity access, and algorithmic execution.

7. Market Impact Management

The Company manages market impact through order slicing, execution timing, participation-rate algorithms, pre-trade impact models, and post-trade TCA.

8. Conflicts of Interest

The Company does not engage in proprietary trading that conflicts with investor execution.

9. Order Aggregation

Where orders are aggregated, allocation is on a fair pro-rata basis.

10. Monitoring

The Company conducts regular transaction cost analysis (TCA), venue review, and slippage analysis.

Monitoring outcomes inform ongoing refinement of execution arrangements, venue selection, and controls in line with this Policy.

Regulatory framework

Execution under this Policy is carried out with regard to the Company's authorisation by the Financial Services Commission (FSC) of Mauritius and applicable regulatory requirements.

Inquiries

Institutional and professional investors may request further information on execution arrangements from the Company, subject to confidentiality and applicable law.

11. Investor Consent

The investor acknowledges and consents to this Policy.

Drovix (MU) Ltd | Financial Services Commission (FSC) of Mauritius | License No. GB21026813